Profiel
George M.
Stuart was Senior Vice President of Finance and Chief Financial Officer of Questcor Pharmaceutical, Inc., which he joined in September 2005.
Prior to joining Questcor, he served as Vice President of Finance, Chief Financial Officer and Treasurer of Xcel Pharmaceuticals, Inc. from April 2001 to June 2005.
Mr. Stuart was a Co-Founder of Xcel.
From May 1999 to April 2001, he was Director of Corporate Accounting for Ligand Pharmaceuticals, Inc. He received a BS in Accounting from San Diego State University and is a Certified Public Accountant.
Eerdere bekende functies van George M. Stuart
| Bedrijven | Functie | Einde |
|---|---|---|
| QUESTCOR PHARMACEUTICALS INC | Financieel Directeur/CFO | 11-09-2008 |
Xcel Pharmaceuticals, Inc.
 Xcel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA | Oprichter | 28-09-2005 |
| LIGAND PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | 01-04-2001 |
Opleiding van George M. Stuart
| San Diego State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Xcel Pharmaceuticals, Inc.
Xcel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA | Health Technology |
